Data / Form D filings / SwitchPoint Bio Holding, Inc.
SwitchPoint Bio Holding, Inc.: Form D filing
SwitchPoint Bio Holding, Inc., a biotechnology company in Wilmington, DE, filed a Form D with the SEC in 2026. The latest, on March 10, 2026, reports $5.3 million sold of a $5.3 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 251 LITTLE FALLS DRIVE, Wilmington, DE, 19808
- Phone
- (650) 996-9693
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 2113353
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | New notice | $5,270,000 | $5,270,000 | 6 | Mar 9, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Samuel Myllykangas | Executive Officer, Director | |
| Jussi Paananen | Executive Officer, Director | |
| David Proctor | Director |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Mar 9, 2026 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SwitchPoint Bio Holding, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.